Works matching IS 15747891 AND DT 2022 AND VI 16 AND IP 22
Results: 14
KRAS inhibitors: going noncovalent.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 3911, doi. 10.1002/1878-0261.13341
- By:
- Publication type:
- Article
Retraction statement: HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1‐IT2‐dependent manner.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 4063, doi. 10.1002/1878-0261.13334
- Publication type:
- Article
Retraction statement: HBx‐mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 4062, doi. 10.1002/1878-0261.13333
- Publication type:
- Article
Retraction statement: Down‐regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA‐145‐mediated inhibition of FSCN1.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 4061, doi. 10.1002/1878-0261.13332
- Publication type:
- Article
Artificial intelligence‐driven consensus gene signatures for improving bladder cancer clinical outcomes identified by multi‐center integration analysis.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 4023, doi. 10.1002/1878-0261.13313
- By:
- Publication type:
- Article
Retraction statement: Consistency analysis of microRNA‐arm expression reveals microRNA‐369‐5p/3p as tumor suppressors in gastric cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 4060, doi. 10.1002/1878-0261.13331
- Publication type:
- Article
Immune‐related gene TM4SF18 could promote the metastasis of gastric cancer cells and predict the prognosis of gastric cancer patients.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 4043, doi. 10.1002/1878-0261.13321
- By:
- Publication type:
- Article
The prevalence and prognosis of next‐generation therapeutic targets in metastatic castration‐resistant prostate cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 4011, doi. 10.1002/1878-0261.13320
- By:
- Publication type:
- Article
Hyaluronic acids mediate the infiltration, migration, and M2 polarization of macrophages: evaluating metabolic molecular phenotypes in gliomas.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 3927, doi. 10.1002/1878-0261.13315
- By:
- Publication type:
- Article
Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 3949, doi. 10.1002/1878-0261.13322
- By:
- Publication type:
- Article
Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 3916, doi. 10.1002/1878-0261.13311
- By:
- Publication type:
- Article
Regulation of the THRA gene, encoding the thyroid hormone nuclear receptor TRα1, in intestinal lesions.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 3975, doi. 10.1002/1878-0261.13298
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 3909, doi. 10.1002/1878-0261.13009
- Publication type:
- Article
Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 22, p. 3994, doi. 10.1002/1878-0261.13314
- By:
- Publication type:
- Article